{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:28:14Z","timestamp":1761823694976},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-833","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T08:01:56Z","timestamp":1416297716000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Angelo","family":"Tozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Iftode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Ascolese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Concetta","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Comito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorenza","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fogliata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mancosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tomatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"5026_CR1","first-page":"815","volume":"24","author":"TM Zagar","year":"2010","unstructured":"Zagar TM, Willett CG, Czito BG: Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes. Oncology. 2010, 24: 815-823. 828","journal-title":"Oncology"},{"key":"5026_CR2","first-page":"1082","volume":"23","author":"BG Czito","year":"2009","unstructured":"Czito BG, Pepek JM, Meyer JJ, Yoo S, Willet CG: Intensity-modulated radiation therapy for anal cancer. Oncology. 2009, 23: 1082-1089.","journal-title":"Oncology"},{"key":"5026_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.radonc.2013.03.012","volume":"107","author":"T Dasgupta","year":"2013","unstructured":"Dasgupta T, Rothenstein D, Chou JF, Zhang Z, Wright J, Saltz L, Temple L, Paty P, Weiser M, Guillem J, Nash G, Goodman K: Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiother Oncol. 2013, 107: 189-194. 10.1016\/j.radonc.2013.03.012.","journal-title":"Radiother Oncol"},{"key":"5026_CR4","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1002\/cncr.25901","volume":"117","author":"JG Bazan","year":"2011","unstructured":"Bazan JG, Hara W, Hsu A, Kunz P, Ford J, Fisher G, Welton M, Shelton A, Kapp D, Koong A, Goodman K, Chang D: Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011, 117: 3342-3351. 10.1002\/cncr.25901.","journal-title":"Cancer"},{"key":"5026_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1748-717X-7-45","volume":"7","author":"S Vieillot","year":"2012","unstructured":"Vieillot S, Fenoglietto P, Lemanski C, Moscardo C, Gourgou S, Dubois J, Ailleres N, Azria D: IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center. Radiat Oncol. 2012, 7: 45-10.1186\/1748-717X-7-45.","journal-title":"Radiat Oncol"},{"issue":"2","key":"5026_CR6","first-page":"39","volume":"6","author":"MD Chuong","year":"2013","unstructured":"Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber J, Almhanna K, Dinwoodie W, Rao N, Meredith K, Shridhar R: Intensity-modulated radiation therapy vs. 3d conformal radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Canc Res. 2013, 6 (2): 39-45.","journal-title":"Gastrointest Canc Res"},{"key":"5026_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clon.2011.09.014","volume":"24","author":"SG DeFoe","year":"2012","unstructured":"DeFoe SG, Beriwal S, Jones H, Rakfal S, Heron D, Kabolizadeh P, Smith R, Lalonde R: Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma d clinical outcomes in a Large National Cancer Institute-designated Integrated Cancer Centre Network. Clin Oncol. 2012, 24: 424-431. 10.1016\/j.clon.2011.09.014.","journal-title":"Clin Oncol"},{"key":"5026_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","volume":"82","author":"LA Kachnic","year":"2012","unstructured":"Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky L, Hartshorn K, Kwak E, Willins J, Ryan D, Hong T: Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiation Oncology Biol Phys. 2012, 82: 153-158. 10.1016\/j.ijrobp.2010.09.030.","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"5026_CR9","doi-asserted-by":"publisher","first-page":"27e33","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear M, Willins J, Esthappan J, Haddock M, Rotman M, Parikh P, Safran H, Willett C: RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiation Oncol Biol Phys. 2013, 86: 27e33-","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"5026_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","volume":"37","author":"MP Mitchell","year":"2014","unstructured":"Mitchell MP, Abboud M, Eng C, Beddar A, Krishnan S, Delclos M, Crane C, Das P: Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol. 2014, 37: 461-466. 10.1097\/COC.0b013e31827e52a3.","journal-title":"Am J Clin Oncol"},{"key":"5026_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1748-717X-5-92","volume":"5","author":"S Vieillot","year":"2010","unstructured":"Vieillot S, Azria D, Lemanski C, Moscardo C, Gourgou S, Dubois J, Ailleres N, Fenoglietto P: Plan comparison of volumetric modulated arc therapy (RapidArc) and conventional intensity modulated radiation therapy (IMRT) in anal canal cancer. Radiat Oncol. 2010, 5: 92-10.1186\/1748-717X-5-92.","journal-title":"Radiat Oncol"},{"key":"5026_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.radonc.2008.12.020","volume":"92","author":"A Clivio","year":"2009","unstructured":"Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, Cozzi L: Volumetric modulated arc radiotherapy for carcinomas of the anal canal: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009, 92: 118-124. 10.1016\/j.radonc.2008.12.020.","journal-title":"Radiother Oncol"},{"key":"5026_CR13","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","volume":"83","author":"H Gay","year":"2012","unstructured":"Gay H, Barthold J, O\u2019Meara E, Bosch W, El Naqa I, Al-Lozi R, Rosenthal S, Lawton C, Lee W, Sandler H, Zietta A, Myerson R, Dawson L, Willett C, Kachnic L, Jhingran A, Portelance L, Ryu J, Small W, Gaffney D, Viswanathan A, Michalski J: Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012, 83: e353-e362. 10.1016\/j.ijrobp.2012.01.023.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5026_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"R Myerson","year":"2009","unstructured":"Myerson R, Garofalo M, El Naqa I, Abrams R, Apte A, Bosch W, Das P, Gunderson L, Hong T, Kim J, Willett C, Kachnic L: Elective clinical target volumes for conformal therapy in anorectal c\u00e1ncer: an RTOG consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009, 74: 824-830. 10.1016\/j.ijrobp.2008.08.070.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5026_CR15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J, Kneebone A, Carrol S, Wittshire K, Ngan S, Kachnic L: Australasian gastrointestinal trials group (AGITG). Contouring atlas and planning guidelines for intensity modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012, 83: 1455-1462. 10.1016\/j.ijrobp.2011.12.058.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5026_CR16","volume-title":"Prescribing, Recording and Reporting Photon Beam Therapy","author":"ICRU Report 62","year":"1999","unstructured":"ICRU Report 62: Prescribing, Recording and Reporting Photon Beam Therapy. 1999, Washington, DC: International Commission on Radiation Units and Measurements"},{"key":"5026_CR17","volume-title":"Prescribing, Recording and REPORTING INTENSITY Modulated Photon Beam Therapy (IMRT)","author":"ICRU Report 83","year":"2010","unstructured":"ICRU Report 83: Prescribing, Recording and REPORTING INTENSITY Modulated Photon Beam Therapy (IMRT). 2010, Washington, DC: International Commission on Radiation Units and Measurements"},{"key":"5026_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan R, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom A, Christian M, Gwyther S: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"key":"5026_CR19","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"J Ajani","year":"2008","unstructured":"Ajani J, Winters KA, Gunderson LL, Pedersen J, Benson A, Thomas C, Mayer R, Haddock M, Rich T, Willett C: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, amd radiotherapy for carcinoma of the anal canal: a randomized controlled trial. J Am Med Ass. 2008, 299: 1914-1921. 10.1001\/jama.299.16.1914.","journal-title":"J Am Med Ass"},{"key":"5026_CR20","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset J, Gonzalez D, Pfeiffert D, van Glabbeke M, Pierart M: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer. Results of a phase III randomized trial of European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol. 1997, 15: 2040-2049.","journal-title":"J Clin Oncol"},{"key":"5026_CR21","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman K, Kerman H, Coia L, Murray K: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996, 14: 2527-2539.","journal-title":"J Clin Oncol"},{"key":"5026_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR","year":"1996","unstructured":"UKCCCR: Anal Cancer Working Party, UK Co-ordinating Committee on Cancer Research: Epidermoid Anal Cancer. Results from the UKCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996, 348: 1049-1054.","journal-title":"Lancet"},{"key":"5026_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"R James","year":"2013","unstructured":"James R, Glynne-Jones R, Meadows H, Cunningham D, Myint A, Saunders M, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D: Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013 May, 14: 516-524. 10.1016\/S1470-2045(13)70086-X.","journal-title":"Lancet Oncol"},{"key":"5026_CR24","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"L Gunderson","year":"2012","unstructured":"Gunderson L, Winter K, Ajani J, Pedersen J, Moughan J, Benson A, Thomas C, Mayer R, Haddock M, Rich T, Willett C: Long term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin vertsus fluorouracil.cisplatin. J Clin Oncol. 2012, 30: 4344-4351. 10.1200\/JCO.2012.43.8085.","journal-title":"J Clin Oncol"},{"key":"5026_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000071200","volume":"65","author":"R Graf","year":"2003","unstructured":"Graf R, Wust P, Hildebrandt B, Goegler H, Ullrich R, Hermann R, Riess H, Felix R: Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology. 2003, 65: 14-22. 10.1159\/000071200.","journal-title":"Oncology"},{"key":"5026_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","volume":"50","author":"DC Weber","year":"2001","unstructured":"Weber DC, Kurtz JM, Allal AS: The impact of gap duration on local control of anal cancer treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys. 2001, 50: 675-680. 10.1016\/S0360-3016(01)01510-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5026_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0002-9343(89)80702-8","volume":"87","author":"JA Ajani","year":"1989","unstructured":"Ajani JA, Carrasco CH, Jackson DE, Wallace S: Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med. 1989, 87: 221-224. 10.1016\/S0002-9343(89)80702-8.","journal-title":"Am J Med"},{"key":"5026_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0360-3016(96)00146-0","volume":"35","author":"JA Martenson","year":"1996","unstructured":"Martenson JA, Lipsitz SR, Wagner H, Kaplan E, Otteman L, Schuchter L, Mansour E, Talamonti M, Benson A: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996, 35: 745-749. 10.1016\/0360-3016(96)00146-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5026_CR29","first-page":"34","volume":"1","author":"SV Dandapani","year":"2010","unstructured":"Dandapani SV, Eaton M, Thomas CR, Pagnini P: HIV\u2013 positive anal cancer: an update for the clinician. Review Article. J Gastrointest Oncol. 2010, 1: 34-44.","journal-title":"J Gastrointest Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-833\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:31:59Z","timestamp":1630564319000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5026"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-833","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]},"assertion":[{"value":"25 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"833"}}